Nobivac Lepto
Nobivac Lepto
Not authorised
- Leptospira interrogans, serovar Copenhageni, strain Ic-02-001, Inactivated
- Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
Product identification
Medicine name:
Nobivac Lepto
Active substance:
- Leptospira interrogans, serovar Copenhageni, strain Ic-02-001, Inactivated
- Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Leptospira interrogans, serovar Copenhageni, strain Ic-02-001, Inactivated699.00/unit(s)1.00Dose
-
Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated990.00/unit(s)1.00Dose
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Luxembourg
Package description:
- Plasic box containing 50 type I glass vials of 1 ml (1 dose) closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap
- Plasic box containing 10 type I glass vials of 1 ml (1 dose) closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap
- Cardboard box containing 50 type I glass vials of 1 ml (1 dose) closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap
- Cardboard box containing 10 type I glass vials of 1 ml (1 dose) closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
- V 817/03/04/0752
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0108/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet